Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa

Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa

Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria therapy in endemic countries worldwide. This systematic review aims at presenting the current scenario of drug resistance molecular markers, either selected or involved in treatment failures (TF) during in vivo...

Full description

Bibliographic Details
Main Authors: Aditi Arya, Loick P. Kojom Foko, Shewta Chaudhry, Amit Sharma, Vineeta Singh
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:International Journal for Parasitology: Drugs and Drug Resistance
Subjects:
Artemisinin-based combination therapy (ACT)
Drug resistance molecular markers
Failure treatment
Sub-Saharan African countries
India
Online Access:http://www.sciencedirect.com/science/article/pii/S2211320720300488

Internet

http://www.sciencedirect.com/science/article/pii/S2211320720300488

Similar Items